When the Quality of Evidence Just Doesn't Make the Grade in Cancer Care

Maurie Markman, MD
Published: Friday, May 10, 2019
Maurie Markman, MD

Maurie Markman, MD
Some subjects in clinical medicine appear to be out-of bounds for open discussion. Consider the recent story in an otherwise prudent newspaper (The Jerusalem Post) that a pharmaceutical company that had only tested a novel drug in mice would have “a cure for cancer within a year.”1 Of course, once it was printed in this newspaper, other media outlets reported the same nonsense. So, the question to be asked is: To what degree should reputable journalists and mainstream news organizations ensure at least a modest degree of authenticity in their reporting?
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication